Nuvation Bio (NYSE: NUVB) recently received a number of ratings updates from brokerages and research firms: 6/3/2024 – Nuvation Bio had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock. 5/24/2024 – Nuvation Bio had its “outperform” rating reaffirmed by analysts at Wedbush. They now […]

Related Keywords

Canada , Nuvation Bio , Beacon Pointe Advisors , Pinnacle Wealth Planning Services Inc , Nuvation Bio Inc , News Ratings For Nuvation Bio Inc Daily , Royal Bank , Susquehanna Fundamental Investments , Exchange Traded Concepts , Get Free Report , Pointe Advisors , Fundamental Investments , Wealth Planning Services , Capital Management , Traded Concepts , Bio Inc , Nuvation Bio Inc Daily ,